Salani, Jumarija A.

HRN: 16-48-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
METRONIDAZOLE 500MG (TAB)
06/07/2024
06/13/2024
PO
1 Tab
TID
Amoebiasis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: